Organic Synthesis and Medicinal Chemistry

Dr. Sanaa Musa

Our research group focuses on the design and synthesis of hybrid molecules as potential candidates for innovative drug development.

 

Our current research areas include:

  • Development of nitric oxide (NO) and hydrogen sulfide (H2S) hybrid donor compounds based on a cannabinoid scaffold, exploring their dual activity in cardiovascular and neurodegenerative diseases.

     

  • Synthesis of Schiff base–cannabinoid hybrid compounds and evaluation of their biological effects on the melanogenesis process.

     

  • Development of platinum-based hybrid complexes with a particular emphasis on their potential as anti-cancer agents (in collaboration with Prof. Jamal Mahajna).

     

  • Microencapsulation technology for bioactive compounds, focusing on their stability and controlled release to enhance the shelf life of various food products.